CIBC Asset Management Inc Has $1 Million Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

CIBC Asset Management Inc lessened its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 7.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 28,158 shares of the medical instruments supplier’s stock after selling 2,312 shares during the period. CIBC Asset Management Inc’s holdings in DENTSPLY SIRONA were worth $1,002,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Bar Harbor Wealth Management bought a new position in shares of DENTSPLY SIRONA during the 4th quarter worth about $4,931,000. DAVENPORT & Co LLC bought a new position in DENTSPLY SIRONA in the fourth quarter worth approximately $1,220,000. Dimensional Fund Advisors LP grew its stake in DENTSPLY SIRONA by 10.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,122,355 shares of the medical instruments supplier’s stock valued at $75,535,000 after acquiring an additional 197,431 shares during the period. Envestnet Asset Management Inc. increased its holdings in shares of DENTSPLY SIRONA by 98.1% during the third quarter. Envestnet Asset Management Inc. now owns 347,220 shares of the medical instruments supplier’s stock valued at $11,861,000 after acquiring an additional 171,958 shares in the last quarter. Finally, Mirabella Financial Services LLP acquired a new position in shares of DENTSPLY SIRONA during the third quarter worth approximately $802,000. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $27.69 on Monday. The business’s fifty day simple moving average is $29.45 and its 200 day simple moving average is $32.36. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA Inc. has a 12 month low of $26.27 and a 12 month high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting analysts’ consensus estimates of $0.42. The company had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.39 EPS. Research analysts expect that DENTSPLY SIRONA Inc. will post 2.02 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 12th. Investors of record on Friday, June 28th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.31%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Analysts Set New Price Targets

A number of brokerages have commented on XRAY. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. The Goldman Sachs Group lowered their target price on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Monday, May 6th. Evercore ISI cut their price target on DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Robert W. Baird lowered their price objective on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research note on Friday, May 3rd. Finally, Needham & Company LLC cut their target price on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research report on Friday, May 3rd. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Moderate Buy” and a consensus price target of $35.22.

Read Our Latest Stock Analysis on DENTSPLY SIRONA

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier bought 3,577 shares of the firm’s stock in a transaction on Friday, May 31st. The stock was acquired at an average cost of $27.95 per share, with a total value of $99,977.15. Following the completion of the transaction, the director now directly owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.52% of the stock is owned by corporate insiders.

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.